{"id":"https://openalex.org/W2013123695","doi":"https://doi.org/10.2165/00002018-200326040-00001","title":"Consumer Adverse Drug Reaction Reporting","display_name":"Consumer Adverse Drug Reaction Reporting","publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W2013123695","doi":"https://doi.org/10.2165/00002018-200326040-00001","mag":"2013123695","pmid":"https://pubmed.ncbi.nlm.nih.gov/12608885"},"language":"en","primary_location":{"id":"doi:10.2165/00002018-200326040-00001","doi":"https://doi.org/10.2165/00002018-200326040-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00002018-200326040-00001","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020000643","display_name":"Kees van Grootheest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Kees van Grootheest","raw_affiliation_strings":["Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands. ac.vangrootheest@lareb.nl","Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands. ac.vangrootheest@lareb.nl","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023409445","display_name":"Linda de Graaf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Linda de Graaf","raw_affiliation_strings":["Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands","Netherlands Pharmacovigilance Centre Lareb"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107852323","display_name":"Lolkje T.W. de Jong\u2010van den Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Lolkje T.W. de Jong-van den Berg","raw_affiliation_strings":["Groningen University Institute for Drug Exploration"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Groningen University Institute for Drug Exploration","institution_ids":["https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020000643"],"corresponding_institution_ids":["https://openalex.org/I4210139651"],"apc_list":{"value":4990,"currency":"USD","value_usd":4990},"apc_paid":null,"fwci":5.3726,"has_fulltext":false,"cited_by_count":115,"citation_normalized_percentile":{"value":0.95260116,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"26","issue":"4","first_page":"211","last_page":"217"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9269999861717224},{"id":"https://openalex.org/keywords/consumer-reporting","display_name":"consumer reporting","score":0.8579999804496765},{"id":"https://openalex.org/keywords/patient-reports","display_name":"patient reports","score":0.8420000076293945},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9940000176429749},{"id":"https://openalex.org/keywords/adverse-event-detection","display_name":"adverse event detection","score":0.5440000295639038},{"id":"https://openalex.org/keywords/signal-detection","display_name":"signal detection","score":0.6669999957084656},{"id":"https://openalex.org/keywords/cross-national-comparison","display_name":"cross-national comparison","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9038587808609009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8751766681671143},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.647741436958313},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5560024380683899},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.53656405210495},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5105017423629761},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.49864625930786133},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4512289762496948},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3727138936519623},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3448718786239624},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003256","descriptor_name":"Community Participation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003256","descriptor_name":"Community Participation","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.2165/00002018-200326040-00001","doi":"https://doi.org/10.2165/00002018-200326040-00001","is_oa":false,"landing_page_url":"https://doi.org/10.2165/00002018-200326040-00001","pdf_url":null,"source":{"id":"https://openalex.org/S49488433","display_name":"Drug Safety","issn_l":"0114-5916","issn":["0114-5916","1179-1942"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Safety","raw_type":"journal-article"},{"id":"pmid:12608885","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12608885","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug safety","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/eb31dffa-1fe4-40b1-9ecc-e96d2ac72e72","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/eb31dffa-1fe4-40b1-9ecc-e96d2ac72e72","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"van Grootheest, K, de Graaf, L & de Jong-van den Berg, LTW 2003, 'Consumer adverse drug reaction reporting - A new step in pharmacovigilance?', Drug Safety, vol. 26, no. 4, pp. 211-217.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/eb31dffa-1fe4-40b1-9ecc-e96d2ac72e72","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/eb31dffa-1fe4-40b1-9ecc-e96d2ac72e72","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Drug Safety, 26(4), 211 - 217. ADIS INT LTD","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1249047937","https://openalex.org/W1494561330","https://openalex.org/W1586151938","https://openalex.org/W1939080369","https://openalex.org/W1971683126","https://openalex.org/W1991389007","https://openalex.org/W1997099331","https://openalex.org/W2027618295","https://openalex.org/W2031528455","https://openalex.org/W2032421759","https://openalex.org/W2041145853","https://openalex.org/W2070780300","https://openalex.org/W2079201211","https://openalex.org/W2093900455","https://openalex.org/W2103832923","https://openalex.org/W2418276532","https://openalex.org/W2424065113"],"related_works":["https://openalex.org/W1994043460","https://openalex.org/W2405790765","https://openalex.org/W2896216967","https://openalex.org/W2028560065","https://openalex.org/W2121066811","https://openalex.org/W2169559966","https://openalex.org/W4388039351","https://openalex.org/W2500919323","https://openalex.org/W2134806789","https://openalex.org/W7074230735"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}